Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)

BACKGROUND: It has been suggested that withdrawal of inhaled corticosteroids (ICS) in COPD patients on maintenance treatment results in deterioration of symptoms, lung function and exacerbations. The aim of this real-life, prospective, multicentric study was to investigate whether withdrawal of ICS...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Andrea, Guerriero, Massimo, Corrado, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122053/
https://www.ncbi.nlm.nih.gov/pubmed/25005873
http://dx.doi.org/10.1186/1465-9921-15-77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122053/
https://www.ncbi.nlm.nih.gov/pubmed/25005873
http://dx.doi.org/10.1186/1465-9921-15-77

Ejemplares similares